|
"To
advance human good and avoid harm, biotechnology must be used
within ethical constraints. It is the task of bioethics to
help society develop those constraints and bioethics, therefore,
must be of concern to all of us."
Chairman's
Bio
Brain Death— Are persons diagnosed with "brain death" really dead? In recent years, numerous questions have been raised about the clinical and ethical validity of the neurological standard for declaring death. The Council explores these questions in Controversies in the Determination of Death.
Newborn Screening Nearly 4 million U.S. newborns undergo genetic screening each year. In the past, such screening was limited to diseases for which effective treatment was available. Now most mandatory programs also screen for conditions with no effective treatment. What are some of the ethical issues to consider when developing public policy on this issue?
__________________
|
We invite you to read
our reports on ethical issues that arise from advances
in biotechnology and biomedical sciences. Such issues
include: determination
of death, human
cloning,
human dignity and bioethics, newborn screening, stem
cell research,
alternative sources of stem cells, end-of-life
care, the regulation
of assisted reproduction, and the uses of biotechnology
that go "beyond
therapy."
|
|
|
Age-Retardation
(Life Extension)
Aging and End-of-Life
Beyond
Therapy (Enhancement)
Biotechnology
and Public Policy
Bioethics Commissions
Bioethics
in Literature
Cloning
Children
Council's
Future Work
Death
Drugs,
Children, & Behavior Control
Genetics
Health Care
Human
Dignity
Memory
Boosting/Suppression
Mood
Control
Nanotechnology
Neuroethics
Newborn Screening
Organ
Transplantation
Professions
Property
in the Body
Research
Ethics
Sex
Selection
Stem
Cells
|
